아시아태평양의 맞춤형 항체 서비스 시장 보고서(2021-2031년) : 범위, 부문, 역학, 경쟁 분석

The Asia Pacific custom antibody services market is projected to grow significantly, reaching approximately USD 167.86 million by 2031, up from USD 68.24 million in 2023, with a compound annual growth rate (CAGR) of 11.9% during this period.

Executive Summary and Market Analysis

The Asia Pacific region is recognized as the fastest-growing market for custom antibody services globally. This market encompasses several countries, including China, Japan, India, South Korea, Australia, and other regions within Asia Pacific. Key drivers of growth in this market include an increasing geriatric population, a rise in chronic and infectious diseases, and a growing demand for advanced medical technologies. Additionally, collaborative efforts among market players to enhance the efficiency of custom antibody services, along with the rapid expansion of the pharmaceutical and biotechnology sectors, are propelling market growth.

Market Segmentation Analysis

The Asia Pacific custom antibody services market can be segmented based on product type, service type, application, disease indication, source, and end user:

1. Product Type: The market is divided into monoclonal, polyclonal, hybridoma, recombinant antibodies, and others. In 2023, monoclonal antibodies held the largest market share.

2. Service Type: This segment includes antibody discovery and development, antibody production services, and others. Antibody discovery and development services dominated the market in 2023.

3. Application: The applications of custom antibodies include immunohistochemistry, western blotting & immunoprecipitation (IP), ELISA, fluorescence-activated cell sorting, mass spectrometry, and others. ELISA was the leading application in 2023.

4. Disease Indication: The market is segmented into oncology, infectious diseases, immunology, cardiovascular diseases, and others, with oncology being the largest segment in 2023.

5. Source: This includes chicken, rabbits, rats, guinea pigs, mouse or humanized mice, and others. The mouse or humanized mice segment was the largest in 2023, further divided into various platforms for monoclonal antibodies and other technologies.

6. End User: The end users of custom antibody services include the life sciences industry, pharmaceutical and biotech companies, academic and research institutes, and contract research organizations (CROs). The life sciences industry held the largest share in 2023.

Market Outlook

The approval of biosimilar products by the Food and Drug Administration (FDA) is expected to enhance patient care by providing more medication options at potentially lower costs. Recent approvals of biosimilars, such as Alymsys and Cimerli, highlight the growing trend in this area. The increasing number of biosimilars can lower treatment costs and improve access to biologic therapies, thereby driving the growth of the custom antibody services market.

Country Insights

The Asia Pacific custom antibody services market includes key countries such as Japan, China, India, South Korea, Australia, and others. China is the largest market in this region as of 2023. The country hosts numerous medical, pharmaceutical, and biotechnology companies, with over 300 medical CROs that utilize custom antibody services for developing specific antibodies for research and drug development. For instance, Bio-Thera Solutions, a Chinese biotech firm, received significant funding to advance its monoclonal antibody pipeline, which is crucial for various applications including drug discovery and diagnostics. Furthermore, partnerships like that of Sino Biological, Inc. with Rapid Novor, Inc. to market monoclonal antibody sequencing services indicate a growing trend towards collaboration in the industry.

Company Profiles

Key players in the custom antibody services market include Thermo Fisher Scientific Inc., Sino Biological Inc., GenScript Biotech Corporation, Biochain Incorporated, R&D Systems, Inc., Kaneka Eurogentec S.A., Fortis Life Sciences, Precision Antibody, Biocytogen Pharmaceuticals, Abgenex, Creative Biolabs, Agilent Technologies, Bioklone, and Scantibodies Laboratory, Inc. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to their customers.

Table Of Contents

1. Introduction

• 1.1 Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Secondary Research
• 3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Custom Antibody Services Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis

5. Asia Pacific Custom Antibody Services Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 Increasing Prevalence of Chronic Diseases
  • 5.1.2 Rising Approvals of Biosimilars
• 5.2 Market Restraints
  • 5.2.1 High Costs and Complexities Associated with Antibody Production Using Transgenic Animals
• 5.3 Market Opportunities
  • 5.3.1 Rise in Government Research and Development Activities in Emerging and Developed Economies
• 5.4 Future Trends
  • 5.4.1 Technological Advancements Using Recombinant Antibodies
• 5.5 Impact of Drivers and Restraints:

6. Custom Antibody Services Market - Asia Pacific Analysis

• 6.1 Asia Pacific Custom Antibody Services Market Revenue (US$ Million), 2021-2031
• 6.2 Asia Pacific Custom Antibody Services Market Forecast Analysis

7. Asia Pacific Custom Antibody Services Market Analysis - by End User

• 7.1 Life Science Industry
  • 7.1.1 Overview
  • 7.1.2 Life Science Industry: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 7.2 Pharmaceutical and Biotech Companies
  • 7.2.1 Overview
  • 7.2.2 Pharmaceutical and Biotech Companies: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 7.3 Academic and Research Institutes
  • 7.3.1 Overview
  • 7.3.2 Academic and Research Institutes: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 7.4 Contract Research Organizations
  • 7.4.1 Overview
  • 7.4.2 Contract Research Organizations: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Custom Antibody Services Market Analysis - by Disease Indication

• 8.1 Oncology
  • 8.1.1 Overview
  • 8.1.2 Oncology: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 8.2 Infectious Diseases
  • 8.2.1 Overview
  • 8.2.2 Infectious Diseases: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 8.3 Immunology
  • 8.3.1 Overview
  • 8.3.2 Immunology: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 8.4 Cardiovascular Diseases
  • 8.4.1 Overview
  • 8.4.2 Cardiovascular Diseases: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 8.5 Others
  • 8.5.1 Overview
  • 8.5.2 Others: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Custom Antibody Services Market Analysis - by Source

• 9.1 Chicken
  • 9.1.1 Overview
  • 9.1.2 Chicken: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 9.2 Rabbits
  • 9.2.1 Overview
  • 9.2.2 Rabbits: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 9.3 Rats
  • 9.3.1 Overview
  • 9.3.2 Rats: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 9.4 Guinea Pigs
  • 9.4.1 Overview
  • 9.4.2 Guinea Pigs: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 9.5 Mouse or Humanized Mice
  • 9.5.1 Overview
  • 9.5.2 Mouse or Humanized Mice: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Custom Antibody Services Market Analysis - by Mouse or Humanized Mice

• 10.1 Monoclonal Antibody Platform
  • 10.1.1 Overview
  • 10.1.2 Monoclonal Antibody Platform: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 10.2 BsAb Discovery Platform
  • 10.2.1 Overview
  • 10.2.2 BsAb Discovery Platform: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 10.3 Bispecific ADC Platform
  • 10.3.1 Overview
  • 10.3.2 Bispecific ADC Platform: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 10.4 TCR-Mimic Antibody Platform
  • 10.4.1 Overview
  • 10.4.2 TCR-Mimic Antibody Platform: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 10.5 Anti-GPCR Antibody Technology Platform
  • 10.5.1 Overview
  • 10.5.2 Anti-GPCR Antibody Technology Platform: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 10.6 Others
  • 10.6.1 Overview
  • 10.6.2 Others: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. Asia Pacific Custom Antibody Services Market Analysis - by Application

• 11.1 Immunohistochemistry (IHC)
  • 11.1.1 Overview
  • 11.1.2 Immunohistochemistry (IHC): Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 11.2 Western Blot and IP
  • 11.2.1 Overview
  • 11.2.2 Western Blot and IP: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 11.3 ELISA
  • 11.3.1 Overview
  • 11.3.2 ELISA: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 11.4 Fluorescence-activated cell sorting (FACS)
  • 11.4.1 Overview
  • 11.4.2 Fluorescence-activated cell sorting (FACS): Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 11.5 Mass Spectrometry
  • 11.5.1 Overview
  • 11.5.2 Mass Spectrometry: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 11.6 Others
  • 11.6.1 Overview
  • 11.6.2 Others: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

12. Asia Pacific Custom Antibody Services Market Analysis - by Service Type

• 12.1 Antibody Discovery and Development
  • 12.1.1 Overview
  • 12.1.2 Antibody Discovery and Development: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 12.2 Antibody Production Services
  • 12.2.1 Overview
  • 12.2.2 Antibody Production Services: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 12.3 Others
  • 12.3.1 Overview
  • 12.3.2 Others: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

13. Asia Pacific Custom Antibody Services Market Analysis - by Product Type

• 13.1 Monoclonal
  • 13.1.1 Overview
  • 13.1.2 Monoclonal: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 13.2 Polyclonal hybridoma
  • 13.2.1 Overview
  • 13.2.2 Polyclonal hybridoma: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 13.3 Recombinant antibody
  • 13.3.1 Overview
  • 13.3.2 Recombinant antibody: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 13.4 Others
  • 13.4.1 Overview
  • 13.4.2 Others: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

14. Asia Pacific Custom Antibody Services Market - Country Analysis

• 14.1 Asia Pacific
  • 14.1.1 Asia Pacific Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
    • 14.1.1.1 Asia Pacific Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
    • 14.1.1.2 Japan: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 14.1.1.2.1 Japan: Asia Pacific Custom Antibody Services Market Share - by End User
      • 14.1.1.2.2 Japan: Asia Pacific Custom Antibody Services Market Share - by Disease Indication
      • 14.1.1.2.3 Japan: Asia Pacific Custom Antibody Services Market Share - by Source
      • 14.1.1.2.4 Japan: Asia Pacific Custom Antibody Services Market Share - by Mouse Or Humanized Mice
      • 14.1.1.2.5 Japan: Asia Pacific Custom Antibody Services Market Share - by Application
      • 14.1.1.2.6 Japan: Asia Pacific Custom Antibody Services Market Share - by Service Type
      • 14.1.1.2.7 Japan: Asia Pacific Custom Antibody Services Market Share - by Product Type
    • 14.1.1.3 China: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 14.1.1.3.1 China: Asia Pacific Custom Antibody Services Market Share - by End User
      • 14.1.1.3.2 China: Asia Pacific Custom Antibody Services Market Share - by Disease Indication
      • 14.1.1.3.3 China: Asia Pacific Custom Antibody Services Market Share - by Source
      • 14.1.1.3.4 China: Asia Pacific Custom Antibody Services Market Share - by Mouse Or Humanized Mice
      • 14.1.1.3.5 China: Asia Pacific Custom Antibody Services Market Share - by Application
      • 14.1.1.3.6 China: Asia Pacific Custom Antibody Services Market Share - by Service Type
      • 14.1.1.3.7 China: Asia Pacific Custom Antibody Services Market Share - by Product Type
    • 14.1.1.4 India: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 14.1.1.4.1 India: Asia Pacific Custom Antibody Services Market Share - by End User
      • 14.1.1.4.2 India: Asia Pacific Custom Antibody Services Market Share - by Disease Indication
      • 14.1.1.4.3 India: Asia Pacific Custom Antibody Services Market Share - by Source
      • 14.1.1.4.4 India: Asia Pacific Custom Antibody Services Market Share - by Mouse Or Humanized Mice
      • 14.1.1.4.5 India: Asia Pacific Custom Antibody Services Market Share - by Application
      • 14.1.1.4.6 India: Asia Pacific Custom Antibody Services Market Share - by Service Type
      • 14.1.1.4.7 India: Asia Pacific Custom Antibody Services Market Share - by Product Type
    • 14.1.1.5 South Korea: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 14.1.1.5.1 South Korea: Asia Pacific Custom Antibody Services Market Share - by End User
      • 14.1.1.5.2 South Korea: Asia Pacific Custom Antibody Services Market Share - by Disease Indication
      • 14.1.1.5.3 South Korea: Asia Pacific Custom Antibody Services Market Share - by Source
      • 14.1.1.5.4 South Korea: Asia Pacific Custom Antibody Services Market Share - by Mouse Or Humanized Mice
      • 14.1.1.5.5 South Korea: Asia Pacific Custom Antibody Services Market Share - by Application
      • 14.1.1.5.6 South Korea: Asia Pacific Custom Antibody Services Market Share - by Service Type
      • 14.1.1.5.7 South Korea: Asia Pacific Custom Antibody Services Market Share - by Product Type
    • 14.1.1.6 Australia: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 14.1.1.6.1 Australia: Asia Pacific Custom Antibody Services Market Share - by End User
      • 14.1.1.6.2 Australia: Asia Pacific Custom Antibody Services Market Share - by Disease Indication
      • 14.1.1.6.3 Australia: Asia Pacific Custom Antibody Services Market Share - by Source
      • 14.1.1.6.4 Australia: Asia Pacific Custom Antibody Services Market Share - by Mouse Or Humanized Mice
      • 14.1.1.6.5 Australia: Asia Pacific Custom Antibody Services Market Share - by Application
      • 14.1.1.6.6 Australia: Asia Pacific Custom Antibody Services Market Share - by Service Type
      • 14.1.1.6.7 Australia: Asia Pacific Custom Antibody Services Market Share - by Product Type
    • 14.1.1.7 Rest of APAC: Asia Pacific Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 14.1.1.7.1 Rest of APAC: Asia Pacific Custom Antibody Services Market Share - by End User
      • 14.1.1.7.2 Rest of APAC: Asia Pacific Custom Antibody Services Market Share - by Disease Indication
      • 14.1.1.7.3 Rest of APAC: Asia Pacific Custom Antibody Services Market Share - by Source
      • 14.1.1.7.4 Rest of APAC: Asia Pacific Custom Antibody Services Market Share - by Mouse Or Humanized Mice
      • 14.1.1.7.5 Rest of APAC: Asia Pacific Custom Antibody Services Market Share - by Application
      • 14.1.1.7.6 Rest of APAC: Asia Pacific Custom Antibody Services Market Share - by Service Type
      • 14.1.1.7.7 Rest of APAC: Asia Pacific Custom Antibody Services Market Share - by Product Type

15. Custom Antibody Services Market - Industry Landscape

• 15.1 Overview
• 15.2 Growth Strategies in Custom Antibody Services Market
• 15.3 Organic Growth Strategies
  • 15.3.1 Overview
• 15.4 Inorganic Growth Strategies
  • 15.4.1 Overview

16. Company Profiles

• 16.1 Thermo Fisher Scientific Inc
  • 16.1.1 Key Facts
  • 16.1.2 Business Description
  • 16.1.3 Products and Services
  • 16.1.4 Financial Overview
  • 16.1.5 SWOT Analysis
  • 16.1.6 Key Developments
• 16.2 Sino Biological Inc.
  • 16.2.1 Key Facts
  • 16.2.2 Business Description
  • 16.2.3 Products and Services
  • 16.2.4 Financial Overview
  • 16.2.5 SWOT Analysis
  • 16.2.6 Key Developments
• 16.3 GenScript Biotech Corporation
  • 16.3.1 Key Facts
  • 16.3.2 Business Description
  • 16.3.3 Products and Services
  • 16.3.4 Financial Overview
  • 16.3.5 SWOT Analysis
  • 16.3.6 Key Developments
• 16.4 Biochain Incorporated
  • 16.4.1 Key Facts
  • 16.4.2 Business Description
  • 16.4.3 Products and Services
  • 16.4.4 Financial Overview
  • 16.4.5 SWOT Analysis
  • 16.4.6 Key Developments
• 16.5 R&D Systems, Inc
  • 16.5.1 Key Facts
  • 16.5.2 Business Description
  • 16.5.3 Products and Services
  • 16.5.4 Financial Overview
  • 16.5.5 SWOT Analysis
  • 16.5.6 Key Developments
• 16.6 Kaneka Eurogentec S.A.
  • 16.6.1 Key Facts
  • 16.6.2 Business Description
  • 16.6.3 Products and Services
  • 16.6.4 Financial Overview
  • 16.6.5 SWOT Analysis
  • 16.6.6 Key Developments
• 16.7 Fortis Life Sciences
  • 16.7.1 Key Facts
  • 16.7.2 Business Description
  • 16.7.3 Products and Services
  • 16.7.4 Financial Overview
  • 16.7.5 SWOT Analysis
  • 16.7.6 Key Developments
• 16.8 Precision Antibody (A&G Pharmaceutical, Inc.)
  • 16.8.1 Key Facts
  • 16.8.2 Business Description
  • 16.8.3 Products and Services
  • 16.8.4 Financial Overview
  • 16.8.5 SWOT Analysis
  • 16.8.6 Key Developments
• 16.9 Biocytogen Pharmaceuticals Beijing Co Ltd
  • 16.9.1 Key Facts
  • 16.9.2 Business Description
  • 16.9.3 Products and Services
  • 16.9.4 Financial Overview
  • 16.9.5 SWOT Analysis
  • 16.9.6 Key Developments
• 16.10 Abgenex
  • 16.10.1 Key Facts
  • 16.10.2 Business Description
  • 16.10.3 Products and Services
  • 16.10.4 Financial Overview
  • 16.10.5 SWOT Analysis
  • 16.10.6 Key Developments
• 16.11 Creative Biolabs Inc
  • 16.11.1 Key Facts
  • 16.11.2 Business Description
  • 16.11.3 Products and Services
  • 16.11.4 Financial Overview
  • 16.11.5 SWOT Analysis
  • 16.11.6 Key Developments
• 16.12 Agilent Technologies Inc
  • 16.12.1 Key Facts
  • 16.12.2 Business Description
  • 16.12.3 Products and Services
  • 16.12.4 Financial Overview
  • 16.12.5 SWOT Analysis
  • 16.12.6 Key Developments
• 16.13 Bioklone
  • 16.13.1 Key Facts
  • 16.13.2 Business Description
  • 16.13.3 Products and Services
  • 16.13.4 Financial Overview
  • 16.13.5 SWOT Analysis
  • 16.13.6 Key Developments
• 16.14 Scantibodies Laboratory, Inc.
  • 16.14.1 Key Facts
  • 16.14.2 Business Description
  • 16.14.3 Products and Services
  • 16.14.4 Financial Overview
  • 16.14.5 SWOT Analysis
  • 16.14.6 Key Developments

17. Appendix

• 17.1 About The Insight Partners
• 17.2 Glossary of Terms

?